compare neostigmine and sugammadex's effect during VATS lobectomy

Comparison of sugammadex versus neostigmine in VATS lung lobectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003891

Enrollment

Registered

2019-05-07

Start date

2018-03-20

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : After lobectomy using video thoracoscopic surgery, neostigmine and sugammadex were randomly assigned to patients at the end of anesthesia and compare neostigmine and sugammadex&#39

s effect. once after surgery, 0.05mg/kg, 2 mg / kg, respectively, by intravenous line

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.American Society of Anesthesiologists status Classification I, II or III 2.Patients who were 18 years or older who agreed to participate in the study 3.Elective VATS lobectomy performed at our hospital (operation name after surgery)

Exclusion criteria

Exclusion criteria: 1.Surgery other than VATS lobectomy: wedge resection, pneumonectomy, etc. 2.If you have previously undergone VATS lobectomy 3.If you have previously had a pulmonary lesion (eg, pulmonary TB) 4.conversion to open thoracotomy

Design outcomes

Primary

Measure	Time frame
incidence of pulmonary complications	—

Secondary

Measure	Time frame
duration of chest tube insertion;length of hospital stay;length of intensive care units stay	—

Countries

Korea, Republic of

Contacts

Public ContactTaeYoung Lee

Dong-A University Hospital

pinpd@naver.com+82-51-240-5390

Outcome results